June 2025

Enhanced IOP Control with Anti-VEGF and MMC Surgical Therapy Managing intraocular pressure (IOP) is a critical aspect of treating glaucoma and other ocular conditions that threaten vision. Traditional surgical interventions, while effective, often come with complications such as scarring and inflammation. However, combining anti-VEGF (vascular endothelial growth factor) therapy with mitomycin C (MMC) surgical therapy […]

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Shockingly, much of the vision loss caused by this condition is preventable—if detected early and treated properly. However, a major barrier stands in the way: the high cost of treatment. Many

Optic Nerve Hemoglobin Levels Impact Glaucoma Structure and Function Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive damage to the optic nerve and retinal ganglion cells. While elevated intraocular pressure (IOP) has long been recognized as a major risk factor, emerging research suggests that optic nerve hemoglobin levels may play a